Why the study?
Does mitral valve surgery improve outcomes in patients with heart failure and dilated cardiomyopathy with functional mitral regurgitation?
Does mitral valve surgery improve outcomes in patients with heart failure and dilated cardiomyopathy with functional mitral regurgitation?
This review discusses the role of mitral valve surgery in managing functional mitral regurgitation among patients with heart failure and dilated cardiomyopathy.
Mitral valve surgery for functional MR in HF with dilated cardiomyopathy requires individualized caution; leaves open need for randomized outcome trials.
Functional mitral regurgitation is a significant complication of end-stage cardiomyopathy. Dysfunction of one or more components of the mitral valve apparatus occurs in 39-74% and affects almost all heart failure patients. Survival is decreased in subjects with more than mild mitral regurgitation irrespective of the aetiology of heart failure. The goal of treating functional mitral regurgitation is to slow or reverse ventricular remodelling, improve symptoms and functional class, decrease the frequency of hospitalization for congestive heart failure, slow progression to advanced heart failure (time to transplant) and improve survival. This article reviews the role of mitral valve surgery in patients with heart failure and dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Alamri et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: